Inventor · disambiguated record
Ying Ke
Also filed as: KE YING · KE YING-TSUN
2 granted patents·15 pending applications·0 citations·filing 2018–2023
22Inventor score
Top patents by PatentIndex Score
17 records- 0152US2024317686A1RORyT MODULATOR, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOFSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2021·Application pending·0 cites
- 0251US2024116925A1Salt of nitrogen-containing fused heterocyclic compound or crystal form thereof, and preparation method therefor, pharmaceutical composition thereof, and use thereofSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2022·Application pending·0 cites
- 0351US2025197424A1Quinoline compound and use thereofSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2023·Application pending·0 cites
- 0451US2024197737A1Application of compound in preparation of inhibitory drug targeting erbb2 mutantSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2022·Application pending·0 cites
- 0551US2023330093A1Application of nitrogen-containing saturated heterocyclic compoundSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2021·Application pending·0 cites
- 0651US2025163053A1Crystalline form of nitrogen-containing heterocyclic compound, preparation method therefor and use thereofSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2023·Application pending·0 cites
- 0751US2024262793A1Quinazoline compound, and preparation method therefor and application thereofSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2022·Application pending·0 cites
- 0849US2022380433A1Tmem59 protein dimer or chimeric expression receptor improving t cell functionSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2020·Application pending·0 cites
- 0948US2023365563A1Quinazoline compound and application thereofSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2021·Application pending·0 cites
- 1048US2023028539A1Pharmaceutical composition, complementary kit and application thereofSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2020·Application pending·0 cites
- 1147US2022324868A1Pyrazolone-Fused Pyrimidine Compound, and Preparation Method and Use ThereforSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2020·Application pending·0 cites
- 1246US11683777B2Base station and data uplink transmission abnormal detection methodINST INFORMATION IND·Filed 2020·Granted Jun 20, 2023·0 cites·14 claims
- 1346US2024101552A1Carbonyl heterocyclic compound and application thereofSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2021·Application pending·0 cites
- 1445US2022259210A1Pyrazolone-Fused Pyrimidine Compound, Preparation Method for Same and Applications ThereofSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2020·Application pending·0 cites
- 1545US2022195397A1Immune cell containing tumor antigen recognition receptor and application thereofSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2020·Application pending·0 cites
- 1642US2022048915A1Nitrogen-containing Heterocyclic Compound and Composition Thereof, Preparation Method Therefor, and Application ThereofSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2019·Application pending·0 cites
- 1741US10984288B2Malicious software recognition apparatus and methodINST INFORMATION IND·Filed 2018·Granted Apr 20, 2021·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Ying Ke files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →